A mixture of probiotic bacterial strains for use in the treatment of allergic asthma with recurrent wheezing, preferably in pediatric subjects.

摘要

The present invention relates to a bacterial isolate belonging to Bifidobacterium brev sp. (B632) DSM 24706 for use in the treatment of disorders or diseases or conditions of the respiratory tract and in the treatment of asthma and dyspnea. The present invention also relates to a mixture comprising or alternatively consisting of a bacterial isolate for use in the treatment of disorders or diseases or conditions of the respiratory tract and in the treatment of asthma and dyspnea. The present invention also relates to the treatment of disorders or diseases or conditions of the respiratory tract, comprising a mixture as described above and optionally one or more physiologically and/or pharmacologically acceptable excipients and/or technical excipients; To a composition for use in the treatment of asthma and dyspnea. Such isolates, mixtures and compositions are effectively administered and used to treat pediatric subjects.